PH30761A - An infant formulation fortified with bile salt-activated lipase. - Google Patents

An infant formulation fortified with bile salt-activated lipase.

Info

Publication number
PH30761A
PH30761A PH43285A PH43285A PH30761A PH 30761 A PH30761 A PH 30761A PH 43285 A PH43285 A PH 43285A PH 43285 A PH43285 A PH 43285A PH 30761 A PH30761 A PH 30761A
Authority
PH
Philippines
Prior art keywords
bssl
fortified
bile salt
sequence given
activated lipase
Prior art date
Application number
PH43285A
Other languages
English (en)
Inventor
Bjursell Gunner
Blackberg Lars
Olivecrona Thomas
Herell Olle
Carlson Peter
Nilsson Jeanette
Enerback Sven
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH30761A publication Critical patent/PH30761A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH43285A 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase. PH30761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
PH30761A true PH30761A (en) 1997-10-17

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.

Country Status (44)

Country Link
EP (1) EP0535048B1 (fr)
JP (1) JPH05507201A (fr)
KR (1) KR100212411B1 (fr)
CN (2) CN1075113C (fr)
AP (1) AP207A (fr)
AT (1) ATE151077T1 (fr)
AU (1) AU651979B2 (fr)
BG (1) BG61165B1 (fr)
CA (1) CA2083396C (fr)
CZ (1) CZ287470B6 (fr)
DE (1) DE69125489T2 (fr)
DK (1) DK0535048T3 (fr)
DZ (1) DZ1503A1 (fr)
EG (1) EG19937A (fr)
ES (1) ES2099159T3 (fr)
FI (1) FI114639B (fr)
GR (1) GR3023618T3 (fr)
HK (1) HK62497A (fr)
HR (1) HRP920771B1 (fr)
HU (1) HU215258B (fr)
IE (1) IE911844A1 (fr)
IL (1) IL98273A (fr)
IS (1) IS1751B (fr)
JO (1) JO1694B1 (fr)
LT (1) LT4020B (fr)
LV (1) LV10292B (fr)
MA (1) MA22166A1 (fr)
MY (1) MY111245A (fr)
NO (1) NO322962B1 (fr)
NZ (1) NZ238223A (fr)
PH (1) PH30761A (fr)
PL (1) PL166534B1 (fr)
PT (1) PT97836B (fr)
RO (1) RO114793B1 (fr)
RU (1) RU2140983C1 (fr)
SE (1) SE9001985D0 (fr)
SG (1) SG48078A1 (fr)
SK (1) SK281089B6 (fr)
TN (1) TNSN91041A1 (fr)
TW (1) TW221712B (fr)
UA (1) UA39165C2 (fr)
WO (1) WO1991018923A1 (fr)
YU (1) YU49138B (fr)
ZA (1) ZA913778B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US20090226904A1 (en) * 2005-12-01 2009-09-10 University Of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes
FI3205351T3 (fi) 2010-04-23 2023-07-06 Alexion Pharma Inc Lysosomaalisen kertymätaudin entsyymi
KR20150038636A (ko) 2010-09-09 2015-04-08 시나게바 바이오파르마, 코포레이션 환자에서 리소좀 산 리파제 결핍증의 치료를 위한 리소좀 산 리파제의 용도
WO2012052060A1 (fr) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procédé pour augmenter la vitesse de croissance de nourrissons humains
EP2629789A1 (fr) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Procédé pour augmenter l'absorption d'acides gras insaturés par des nourrissons humains
KR20200018781A (ko) * 2017-06-19 2020-02-20 스위디쉬 오르펀 바이오비트럼 에이비 (피유비엘) 반감기 연장 폴리펩티드를 갖는 융합 단백질
EP4501403A3 (fr) 2019-08-30 2025-05-14 Société des Produits Nestlé S.A. Variantes de lipase modifiées

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000381A1 (fr) * 1983-07-01 1985-01-31 Celltech Limited Proteines, compositions pharmaceutiques, genes, vecteurs, organismes hotes et leurs procedes de production

Also Published As

Publication number Publication date
MY111245A (en) 1999-10-30
TNSN91041A1 (fr) 1992-10-25
AP207A (en) 1992-08-18
MA22166A1 (fr) 1991-12-31
EP0535048A1 (fr) 1993-04-07
CN1326782A (zh) 2001-12-19
CZ164491A3 (cs) 1999-07-14
NO924528L (no) 1992-11-24
CN1064313A (zh) 1992-09-09
PT97836A (pt) 1992-02-28
IL98273A (en) 2005-11-20
WO1991018923A1 (fr) 1991-12-12
NO322962B1 (no) 2006-12-18
JPH05507201A (ja) 1993-10-21
SE9001985D0 (sv) 1990-06-01
ES2099159T3 (es) 1997-05-16
DZ1503A1 (fr) 2004-09-13
DE69125489T2 (de) 1997-08-14
YU95191A (sh) 1994-06-10
EG19937A (en) 2000-12-31
BG97123A (bg) 1993-12-24
AU7964591A (en) 1991-12-31
HRP920771A2 (en) 1997-04-30
HU9203774D0 (en) 1993-03-29
ATE151077T1 (de) 1997-04-15
EP0535048B1 (fr) 1997-04-02
CA2083396C (fr) 2006-09-19
NO924528D0 (no) 1992-11-24
SG48078A1 (en) 1998-04-17
LT4020B (en) 1996-08-26
ZA913778B (en) 1992-02-26
FI114639B (fi) 2004-11-30
AP9100270A0 (en) 1991-07-31
YU49138B (sh) 2004-03-12
SK164491A3 (en) 1995-07-11
BG61165B1 (bg) 1997-01-31
DK0535048T3 (da) 1997-09-29
NZ238223A (en) 1993-05-26
UA39165C2 (uk) 2001-06-15
IS1751B (is) 2000-07-21
LV10292A (lv) 1994-10-20
KR100212411B1 (en) 1999-08-02
HK62497A (en) 1997-05-16
RO114793B1 (ro) 1999-07-30
SK281089B6 (sk) 2000-11-07
HRP920771B1 (en) 1999-10-31
IE911844A1 (en) 1991-12-04
HU215258B (hu) 1998-11-30
CN1075113C (zh) 2001-11-21
FI925453L (fi) 1992-11-30
IS3710A7 (is) 1991-12-02
HUT63184A (en) 1993-07-28
CZ287470B6 (cs) 2000-12-13
AU651979B2 (en) 1994-08-11
PT97836B (pt) 1998-11-30
IL98273A0 (en) 1992-06-21
RU2140983C1 (ru) 1999-11-10
TW221712B (fr) 1994-03-11
JO1694B1 (en) 1992-08-09
LTIP1736A (en) 1995-08-25
DE69125489D1 (de) 1997-05-07
GR3023618T3 (en) 1997-08-29
CA2083396A1 (fr) 1991-12-02
PL166534B1 (pl) 1995-05-31
LV10292B (en) 1995-08-20
FI925453A0 (fi) 1992-11-30

Similar Documents

Publication Publication Date Title
PH30761A (en) An infant formulation fortified with bile salt-activated lipase.
WO1998014592A3 (fr) Transcriptase inverse de la telomerase
AU2738497A (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
PL308222A1 (en) Unsaturated aliphatic dicarboxylic acids
CA2278028A1 (fr) Procede d'amelioration de l'efficacite de transformation
AU1770888A (en) Treatment of periodontal disease
EP0166522A3 (en) Cosmetic preparation
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
AU2670495A (en) Ifn-beta liquid formulations
PL350165A1 (en) Detergent cosmetic compositions and use
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
CA2306628A1 (fr) Formulations cosmetiques permettant de prevenir et de traiter la chute des cheveux
GR3004556T3 (fr)
EP0293766A3 (fr) Emulsions
IT8847640A0 (it) Dispositivo per la conservazione prolungata di prodotti al riparo dall'ossigeno dell'aria
EP1591528A3 (fr) Procedes et compositions pour l'administration et l'expression d'acides nucleiques codant l'interferon alpha
CA2108358A1 (fr) Expression de genes dans des bacilles
EP0317279A3 (fr) Peptides pour l'usage dans la purification du facteur-VIII
CA2293367A1 (fr) Esters de cire enrichis en acides gras .omega.-3 insatures, leur preparation et leur utilisation
Gharavi Molecular cloning of the human lipoxygenase gene
Torma Edward Albee’s Tiny Alice: alienation and desire in the religious subject
WO2001036458A3 (fr) Homologue ced-6 de la drosophile
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.
IT8422818A0 (it) Procedimento di verniciatura decorativa di manufatti in legno e prodotti cosi' ottenuti.
IT1216383B (it) Metodo per adornare oggetti metallici,in particolare oggetti decorativi per arte funeraria o per la casa, e oggetti cosi'ottenuti